Transforming Spine Surgery Through Personalized Solutions
Our mission is to improve outcomes and decrease the cost of healthcare for spine surgery and beyond. The Carlsmed aprevo® personalized surgery platform is designed to improve the standard of care for spine surgery one patient at a time.
Advancing what’s possible through personalized spinal solutions
Each device is tailored to the individual patient –
explore why patients want personalized care and how it makes a difference.
Latest Investor News
- November 10, 2026Carlsmed® Reports Third Quarter 2026 Financial Results and Raises Full-Year Guidance
Third quarter 2026 revenue of $21.6 million, representing 65% growth year-over-year Full year 2026 revenue guidance raised to $78 million to $80 million CARLSBAD, Calif., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company
- October 27, 2026Carlsmed, Inc. to Report Third Quarter 2026 Financial Results on November 10, 2026
CARLSBAD, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report its third quarter 2026 financial results after market close on
- October 14, 2026Carlsmed Launches aprevo® Lumbar Bi-lateral Posterior System
CARLSBAD, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced the U.S. commercial launch of its aprevo ® Lumbar Bi-lateral Posterior System at the North American Spine Society’s 41 st Annual Meeting (NASS) in San Antonio, TX.
